Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.47 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.41 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | LCK | P06239 | 1/20 | 0.41 |
| ▸ | PPARD | Q03181 | 1/20 | 0.41 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.41 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | HRH1 | P35367 | 1/20 | 0.39 |
| ▸ | DRD3 | P35462 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3167000 | 0.94 | GPR84 (0.55) | CA2MAPK1GPR84FFAR1SLC1A2 | |
| SCHEMBL3166745 | 0.92 | GPR84 (0.59) | GPR84FFAR1SLC1A2SLC1A1MAPT | |
| SCHEMBL3160912 | 0.92 | GPR84 (0.59) | GPR84FFAR1SLC1A2SLC1A1MAPT | |
| SCHEMBL3169903 | 0.86 | — | — | |
| SCHEMBL1401236 | 0.80 | CA2 (0.50) | CA2MAPK1GPR84FFAR1SLC1A3 | |
| SCHEMBL316535 | 0.78 | CA2 (0.48) | CA2MAPK1GPR84FFAR1SLC1A3 | |
| SCHEMBL966443 | 0.77 | — | — | |
| SCHEMBL6539103 | 0.74 | MAPT (0.55) | CA2MAPK1GPR84FFAR1SLC1A2 | |
| SCHEMBL23829652 | 0.72 | GPR84 (0.50) | CA2MAPK1GPR84FFAR1SLC1A2 | |
| SCHEMBL4002470 | 0.72 | MAPT (0.59) | CA2GPR84FFAR1SLC1A2SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100011656-A1 | USE OF RYLENES AS MARKERS FOR LIQUIDS | BASF SE (DE) | 2010-01-21 | — | — | US | disclosed |
| US-20090124732-A1 | Rylene Tetracarboxylic Acid Diimides Substituted By Cyclic Amino Groups | BASF AKTIENGESELLSCHAFT (DE) | 2009-05-14 | — | — | US | disclosed |
| US-7521556-B2 | 1,6,9,14-tetrasubstituted terrylene tetracarboxylic acid diimides | BASF SE (DE) | 2009-04-21 | — | — | US | disclosed |
| US-20050222416-A1 | 1,6,9,14-teltrasubstituted terrylene tetracarboxylic diimides | BASF AKTIENGESELLSCHAFT (DE) | 2005-10-06 | — | — | US | disclosed |
| US-6184378-B1 | PIGMENTS, LASER DYES AND PRECURSORS FOR PREPARING FLUORESCENT DYES, POLYMERIC COLORANTS, | BASF AKTIENGESELLSCHAFT (DE) | 2001-02-06 | — | — | US | disclosed |
| US-6063181-A | 1,7-disubstituted perylene-3,4,9, 10-tetracarboxylic acids, their dianhydrides and diimides of said acids | BASF AKTIENGESELLSCHAFT (DE) | 2000-05-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090124732-A1 | Rylene Tetracarboxylic Acid Diimides Substituted By Cyclic Amino Groups | NR1I3, NR1I2, NR1H3 | CA2 1578/4885MAPK1 2308/4885GPR84 535/4885 |
| US-20050222416-A1 | 1,6,9,14-teltrasubstituted terrylene tetracarboxylic diimides | CNR2, CNR1, CBR1 | CA2 974/4885MAPK1 3033/4885GPR84 259/4885 |
| US-20100011656-A1 | USE OF RYLENES AS MARKERS FOR LIQUIDS | RPL22, PROX1, RPL29 | CA2 2525/4885MAPK1 2357/4885GPR84 2433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.